Kezhong Chen

4.2k total citations
65 papers, 1.0k citations indexed

About

Kezhong Chen is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Kezhong Chen has authored 65 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 27 papers in Cancer Research and 18 papers in Oncology. Recurrent topics in Kezhong Chen's work include Lung Cancer Treatments and Mutations (34 papers), Cancer Genomics and Diagnostics (26 papers) and Lung Cancer Diagnosis and Treatment (25 papers). Kezhong Chen is often cited by papers focused on Lung Cancer Treatments and Mutations (34 papers), Cancer Genomics and Diagnostics (26 papers) and Lung Cancer Diagnosis and Treatment (25 papers). Kezhong Chen collaborates with scholars based in China, United States and United Kingdom. Kezhong Chen's co-authors include Fan Yang, Jun Wang, Jun Wang, Heng Zhao, Yuntao Nie, Guannan Kang, Yun Li, Yanbin Shi, Guanchao Jiang and Xun Wang and has published in prestigious journals such as Cancer Cell, Cancer Research and Scientific Reports.

In The Last Decade

Kezhong Chen

58 papers receiving 997 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kezhong Chen China 17 714 480 253 229 159 65 1.0k
Naixin Liang China 14 437 0.6× 214 0.4× 523 2.1× 248 1.1× 108 0.7× 34 906
Olga Martínez‐Sáez Spain 11 343 0.5× 298 0.6× 458 1.8× 293 1.3× 95 0.6× 60 832
Cheng‐Bo Han China 17 471 0.7× 190 0.4× 381 1.5× 270 1.2× 112 0.7× 76 864
Zoe Wainer Australia 10 826 1.2× 164 0.3× 386 1.5× 150 0.7× 191 1.2× 12 990
Nicholas Goel United States 10 243 0.3× 226 0.5× 453 1.8× 210 0.9× 196 1.2× 28 807
Sehhoon Park South Korea 18 601 0.8× 229 0.5× 543 2.1× 203 0.9× 85 0.5× 68 895
Jie‐Tao Ma China 15 364 0.5× 153 0.3× 311 1.2× 198 0.9× 96 0.6× 43 677
M. Dusart Belgium 6 901 1.3× 168 0.3× 416 1.6× 263 1.1× 461 2.9× 11 1.2k
W. Torre Spain 14 494 0.7× 115 0.2× 238 0.9× 281 1.2× 152 1.0× 47 912
Giuliana Restante Italy 13 328 0.5× 297 0.6× 322 1.3× 340 1.5× 65 0.4× 25 721

Countries citing papers authored by Kezhong Chen

Since Specialization
Citations

This map shows the geographic impact of Kezhong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kezhong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kezhong Chen more than expected).

Fields of papers citing papers by Kezhong Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kezhong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kezhong Chen. The network helps show where Kezhong Chen may publish in the future.

Co-authorship network of co-authors of Kezhong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Kezhong Chen. A scholar is included among the top collaborators of Kezhong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kezhong Chen. Kezhong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Guihui, Haodong Lin, Xiao Albert Zhou, et al.. (2025). Loss of FTSJ3 promotes R-loop-associated DNA damage and facilitates chemosensitivity in lung cancer cells. Cancer Letters. 631. 217877–217877.
2.
Wang, Wenxiang, Sida Cheng, Fanjie Meng, et al.. (2025). Multiomics elucidation of surrounding AT2 cells impeding tertiary lymphoid structures function in neoadjuvant chemoimmunotherapy response of multiple primary lung cancers. Journal for ImmunoTherapy of Cancer. 13(10). e011882–e011882. 1 indexed citations
3.
Xiao, Yuxuan, Xin Jing, Lin Weng, et al.. (2025). Organoid models in oncology: advancing precision cancer therapy and vaccine development. Cancer Biology and Medicine. 22(8). 1–25. 3 indexed citations
4.
Wang, Peiyu, Guangxi Wang, Haoran Li, et al.. (2024). Nicotinamide N‐methyltransferase negatively regulates metastasis‐promoting property of cancer‐associated fibroblasts in lung adenocarcinoma. Cancer Communications. 45(2). 110–137. 4 indexed citations
5.
Meng, Fanjie, Hao Li, Airong Yang, et al.. (2024). Spatial immunogenomic patterns associated with lymph node metastasis in lung adenocarcinoma. Experimental Hematology and Oncology. 13(1). 106–106.
7.
Wang, Xin, Weibo Yang, Jun Wang, et al.. (2023). Organ preservation strategies after neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer: a multicenter retrospective cohort study. International Journal of Surgery. 109(8). 2286–2292. 3 indexed citations
8.
Zhang, Siqi, Xiaohong Liu, Lixin Zhou, et al.. (2023). Intelligent prognosis evaluation system for stage I-III resected non-small-cell lung cancer patients on CT images: a multi-center study. EClinicalMedicine. 65. 102270–102270. 3 indexed citations
9.
Wang, Peiyu, Shaodong Wang, Zewen Sun, et al.. (2023). Systemic inflammation influences the prognosis of patients with radically resected non‐small cell lung cancer and correlates with the immunosuppressive microenvironment. International Journal of Cancer. 153(4). 826–842. 12 indexed citations
10.
Chen, Kezhong, Airong Yang, David P. Carbone, et al.. (2022). Spatiotemporal genomic analysis reveals distinct molecular features in recurrent stage I non-small cell lung cancers. Cell Reports. 40(2). 111047–111047. 9 indexed citations
11.
Chen, Kezhong, Heng Zhao, Yanbin Shi, et al.. (2019). Perioperative Dynamic Changes in Circulating Tumor DNA in Patients with Lung Cancer (DYNAMIC). Clinical Cancer Research. 25(23). 7058–7067. 159 indexed citations
12.
14.
Chen, Kezhong, Jingbo Zhang, Fan Yang, et al.. (2017). Comparison of plasma to tissue DNA mutations in surgical patients with non–small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery. 154(3). 1123–1131.e2. 42 indexed citations
15.
Zhou, Lixin, et al.. (2014). Risk factors of recurrence for resected T1aN0M0 invasive lung adenocarcinoma:a clinicopathologic study of 177 patients. Zhonghua shiyan waike zazhi. 31(8). 1639–1641. 1 indexed citations
17.
Yang, Fan, Xiao Li, Kezhong Chen, Guanchao Jiang, & Jun Wang. (2013). Tolerability and toxicity of adjuvant cisplatin and gemcitabine for treating non-small cell lung cancer. Chinese Medical Journal. 126(11). 2087–2091. 2 indexed citations
18.
Zhao, Hui, Jun Wang, Yun Li, et al.. (2011). Application of endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of mediastinal lesions.. PubMed. 124(23). 3988–92. 7 indexed citations
19.
Yang, Fan, Kezhong Chen, Xizhao Sui, et al.. (2011). K-ras mutation-induced resistance to epidermal growth factor receptor inhibitors in lung cancer cells. Zhonghua shiyan waike zazhi. 28(8). 1232–1234. 1 indexed citations
20.
Chen, Kezhong, et al.. (1995). Effects ofCoptis chinensis on lipid peroxidation and antioxidases activity of rats. Chinese Journal of Integrated Traditional and Western Medicine. 1(1). 421–3, 390. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026